ABBV | AbbVie
152.34 2.89 (1.93%)
ABBV Price Profile
Open
$150.89
CLOSE
$152.34
DAY RANGE
149.62 - 152.74
52 WEEK RANGE
105.56 - 175.91
MARKET CAP
256.99B
Trading volume
8.53M
Prev. Close
149.45
50 Day MA
155.16
Shares Outstanding
1.77B
Public Float
1.77B
Average Volume
6.22M
Beta
0.81
PEG Ratio
5.00
Shares Shorted
16.61M
% OF SHARES SHORTED
0.81%
Short Ratio
1.68
1 Year Performance
1962.20%
Diluted EPS (TTM)
6.97
Q Revenue Growth
0.04
Ebitda
25.85B
Gross Profit (TTM)
38.88B
Total Cash (MRQ)
7.57B
Total Debt (MRQ)
73.65B
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
AbbVie (ABBV) company profile
AbbVie Inc. (NYSE: ABBV) is a research company that develops pharmaceutical products. The company offers its products in various therapeutic categories, including immunology, chronic kidney disease, hepatitis C, women’s health, oncology, and neuroscience. AbbVie also provides treatments for specific conditions, including multiple sclerosis, Parkinson’s, and Alzheimer’s.
